 - Any clinically significant co-morbidity or abnormality including psychiatric disorder, any other autoimmune endocrinopathy e.g., primary autoimmune hypothyroidism, hyperadrenalism, coeliac disease etc that in the opinion of the Investigator, may pose additional risk in administering study medication or trial participation 